Insmed Incorporated (BMV:INSM)

Insmed Statistics

Total Valuation

Insmed has a market cap or net worth of MXN 548.57 billion. The enterprise value is 536.73 billion.

Market Cap	548.57B
Enterprise Value	536.73B

Important Dates

The last earnings date was Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	213.27M
Shares Outstanding	n/a
Shares Change (YoY)	+21.32%
Shares Change (QoQ)	+0.89%
Owned by Insiders (%)	0.64%
Owned by Institutions (%)	90.25%
Float	193.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	50.25
PB Ratio	41.23
P/TBV Ratio	57.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-23.35
EV / Sales	50.89
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-30.81

Financial Position

The company has a current ratio of 3.83, with a Debt / Equity ratio of 1.01.

Current Ratio	3.83
Quick Ratio	3.35
Debt / Equity	1.01
Debt / EBITDA	n/a
Debt / FCF	-0.77
Interest Coverage	-11.87

Financial Efficiency

Return on equity (ROE) is -249.28% and return on invested capital (ROIC) is -40.32%.

Return on Equity (ROE)	-249.28%
Return on Assets (ROA)	-28.99%
Return on Invested Capital (ROIC)	-40.32%
Return on Capital Employed (ROCE)	-55.40%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	6.56M
Profits Per Employee	-13.81M
Employee Count	1,664
Asset Turnover	0.28
Inventory Turnover	1.07

Taxes

In the past 12 months, Insmed has paid 90.48 million in taxes.

Income Tax	90.48M
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	n/a
200-Day Moving Average	n/a
Relative Strength Index (RSI)	n/a
Average Volume (20 Days)	842

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.87

Income Statement

In the last 12 months, Insmed had revenue of MXN 10.92 billion and -22.99 billion in losses. Loss per share was -115.58.

Revenue	10.92B
Gross Profit	8.70B
Operating Income	-17.91B
Pretax Income	-22.90B
Net Income	-22.99B
EBITDA	-17.65B
EBIT	-17.91B
Loss Per Share	-115.58

Balance Sheet

The company has 25.75 billion in cash and 13.49 billion in debt, with a net cash position of 12.25 billion.

Cash & Cash Equivalents	25.75B
Total Debt	13.49B
Net Cash	12.25B
Net Cash Per Share	n/a
Equity (Book Value)	13.30B
Book Value Per Share	62.09
Working Capital	23.86B

Cash Flow

In the last 12 months, operating cash flow was -16.83 billion and capital expenditures -586.20 million, giving a free cash flow of -17.42 billion.

Operating Cash Flow	-16.83B
Capital Expenditures	-586.20M
Free Cash Flow	-17.42B
FCF Per Share	n/a

Margins

Gross margin is 79.73%, with operating and profit margins of -164.04% and -210.54%.

Gross Margin	79.73%
Operating Margin	-164.04%
Pretax Margin	-209.71%
Profit Margin	-210.54%
EBITDA Margin	-161.68%
EBIT Margin	-164.04%
FCF Margin	n/a

Dividends & Yields

Insmed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.32%
Shareholder Yield	-21.32%
Earnings Yield	-4.19%
FCF Yield	-3.18%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Insmed has an Altman Z-Score of 5.13 and a Piotroski F-Score of 4.

Altman Z-Score	5.13
Piotroski F-Score	4